PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSomero Regulatory News (SOM)

Share Price Information for Somero (SOM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 347.50
Bid: 340.00
Ask: 355.00
Change: 2.00 (0.58%)
Spread: 15.00 (4.412%)
Open: 345.00
High: 347.00
Low: 346.00
Prev. Close: 345.00
SOM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

19 Jul 2022 07:00

RNS Number : 8731S
Somero Enterprises Inc.
19 July 2022
 

19 July 2022

Somero Enterprises, Inc.

("Somero" or "the Company")

 

Trading Update

Somero® is pleased to provide an update on trading ahead of its interim results announcement scheduled to be released on Wednesday, 7 September 2022.

Driven by positive momentum from a highly active US non-residential construction market, healthy market conditions and elevated activity levels in the European and Australian markets, Group trading in H1 2022 ended higher than the comparable H1 2021 period. 

 

As expected, H1 2022 trading in North America remained strong, increasing from H1 2021, reflective of customers with sizable workloads and project backlogs that extend well into 2023. The breadth and variety of project activity in the US translated to healthy take rates across the Somero product portfolio including continued, strong performance in the boomed screed category.

 

The European market was active during H1 2022, reflective of positive non-residential construction market conditions and a busy customer base with healthy, extended project backlogs. While H1 2022 trading in Europe was down compared to H1 2021, due largely to logistics challenges that delayed machine shipments, based on the H1 2022 momentum and activity levels alongside anticipated catch-up on shipment delays to start H2 2022, second half 2022 trading is anticipated to accelerate, and Europe is anticipated to contribute to full-year 2022 growth. 

 

H1 2022 trading in Australia was also strong, improving from H1 2021, reflecting similar positive market conditions as the US and Europe, in line with the expectation that the region will contribute meaningfully to 2022 growth. Trading in all other regions also fell in line with expectations, including in China where revenues were down compared to H1 2021 due to the previously announced reduced Company focus on the region and the severe impact of COVID restrictions. 

 

New products, including the SkyScreed®, the S-PS50 Laser Screed® and the Somero Broom+CureTM, contributed meaningfully to H1 2022 sales while the Company continues to make good progress in identifying opportunities to penetrate untapped market segments and with development of new solutions for customers.

 

During the first six months of 2022, the also Company made substantial progress with the Houghton, Michigan building expansion project anticipated to be completed by the end of Q3 2022 and with adding new personnel necessary to support future growth of the business, particularly in our primary US, Europe and Australian markets. 

 

While cognizant of the uncertain macro economic environment, the Board continues to anticipate healthy trading to continue in H2 2022, a view underpinned by direct feedback from customers in the US, Europe & Australian indicating high workloads and extended project backlogs. As such, the Board is pleased to confirm 2022 results are anticipated to fall in line with market expectations for revenues of approximately US$ 138.8m, EBITDA of approximately US$ 47.7m, and year-end cash of approximately US$ 39.9m.

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 as retained as part of UK law by virtue of the European Union (Withdrawal) Act 2018 as amended. Upon the publication of this Announcement, this inside information is now considered to be in the public domain.

 

Enquiries:

 

Somero Enterprises, Inc. www.somero.com

Jack Cooney, CEO +1 239 210 6500

John Yuncza, President

Vincenzo LiCausi, CFO

Howard Hohmann, EVP Sales

 

finnCap Ltd (NOMAD and Broker)

Matt Goode (Corporate Finance) +44 (0)20 7220 0500

Kate Bannatyne (Corporate Finance)

Tim Redfern/Richard Chambers (ECM)

 

Alma PR (Financial PR Advisor) somero@almapr.co.uk

David Ison +44 (0)20 3405 0205

Pippa Crabtree

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBKFBKABKDAOD
Date   Source Headline
7th Nov 20172:45 pmRNSHolding(s) in Company
2nd Nov 20177:00 amRNSHolding(s) in Company
21st Sep 20172:20 pmRNSHolding(s) in Company
8th Sep 201712:30 pmRNSTransaction in Own Shares
6th Sep 20177:00 amRNSInterim Results
18th Jul 20177:00 amRNSTrading Update
6th Jun 20172:09 pmRNSResult of AGM
5th Jun 20177:00 amRNSAGM Statement
11th Apr 201712:20 pmRNSAnnual Report and Notice of AGM
3rd Apr 20177:00 amRNSHolding(s) in Company
22nd Mar 20171:42 pmRNSHolding(s) in Company
21st Mar 201712:55 pmRNSHolding(s) in Company
21st Mar 20177:00 amRNSHolding(s) in Company
20th Mar 20177:00 amRNSTransactions in Own Shares and RSUs
17th Mar 20177:00 amRNSDirector Holdings / Transaction in Own Shares
16th Mar 201712:50 pmRNSHolding(s) in Company
15th Mar 20177:00 amRNSFinal Results
3rd Mar 20171:37 pmRNSHolding(s) in Company
27th Feb 20171:53 pmRNSHolding(s) in Company
16th Feb 20171:54 pmRNSHolding(s) in Company
7th Feb 201710:55 amRNSTransaction in Restricted Stock Units
31st Jan 20173:24 pmRNSTransaction in Restricted Stock Units
30th Jan 20174:19 pmRNSHolding(s) in Company
10th Jan 20177:00 amRNSTrading Update
6th Jan 20173:48 pmRNSHolding(s) in Company
3rd Jan 20177:01 amRNSBroking Arrangements
3rd Jan 20177:00 amRNSHolding(s) in Company
17th Nov 20167:00 amRNSHolding(s) in Company
12th Sep 20165:15 pmRNSHolding(s) in Company
12th Sep 20164:19 pmRNSHolding(s) in Company
8th Sep 20164:58 pmRNSHolding(s) in Company
6th Sep 20163:06 pmRNSHolding(s) in Company
6th Sep 20167:00 amRNSInterim Results
17th Aug 20164:56 pmRNSHolding(s) in Company
16th Aug 20162:06 pmRNSHolding(s) in Company
1st Aug 20167:00 amRNSChange of Nomad
14th Jul 20161:57 pmRNSHolding(s) in Company
12th Jul 20167:00 amRNSTrading Update
14th Jun 20165:37 pmRNSHolding(s) in Company
7th Jun 20161:42 pmRNSResult of AGM
6th Jun 20167:00 amRNSTrading Update
23rd May 20165:00 pmRNSHolding(s) in Company
27th Apr 20167:00 amRNSChange of Registered Office Address
31st Mar 20167:00 amRNSDirector/PDMR Shareholding
30th Mar 20162:34 pmRNSHolding(s) in Company
30th Mar 20167:00 amRNSDirector/PDMR Shareholding
29th Mar 20167:00 amRNSTransactions in Own Shares and RSUs
21st Mar 20163:43 pmRNSHolding(s) in Company
21st Mar 20163:13 pmRNSHolding(s) in Company
21st Mar 20167:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.